Go to the list of all blogs
published in Blogs
May 01, 2026
Cisco Systems (CSCO) Stock Rises +17.4% in Last 30 Days: AI Infrastructure Powers the Rally

Cisco Systems (CSCO) Stock Rises +17.4% in Last 30 Days: AI Infrastructure Powers the Rally

Key Takeaways

  • Cisco Systems (CSCO) stock surged +17.4% over the last 30 days, fueled by robust demand for AI infrastructure networking products.
  • Over the past quarter, shares rose +13.5%, recovering from a post-earnings dip amid broader tech sector strength.
  • Strong Q2 FY2026 earnings with 10% revenue growth highlighted AI-driven momentum, despite initial margin concerns.
  • Analyst consensus remains Moderate Buy with price targets around $90, supporting positive market sentiment.
  • Upcoming Q3 earnings and AI trends are key factors influencing near-term stock price movement.

Cisco Systems (CSCO): Company Overview and Market Position

Cisco Systems, Inc. (CSCO) stands as a multinational technology conglomerate specializing in networking hardware, software, telecommunications equipment, and cybersecurity solutions. The company provides products like routers, switches, and collaboration tools, serving enterprises, service providers, and governments worldwide. Its business model revolves around subscription-based software and services, which now account for a growing portion of revenue, alongside traditional hardware sales.

In the competitive networking and IT infrastructure industry, CSCO holds a dominant market position with strong brand loyalty and an extensive patent portfolio. From what I see, its exposure to AI data centers and cloud computing has bolstered fundamentals, explaining the recent resilience in stock price amid tech sector volatility. I also checked this using Tickeron’s AI Screener to confirm how it stacks up against peers.

CSCO Stock Performance: 30 Days vs. the Past Quarter

Over the last 30 days, CSCO stock climbed from a close of approximately $77.93 to $91.50, marking a +17.4% gain. The movement was trend-driven with volatility, featuring steady gains in early April followed by a sharp late-month rally to new 52-week highs near $91.67.

For the past quarter, shares advanced +13.5% from around $80.64 to $91.50. Performance was volatile, including a sharp post-earnings drop in mid-February, a gradual recovery through March, and acceleration in April, reflecting range-bound trading early on before breaking higher. One thing that stands out is how CSCO has mirrored broader tech strength.

Key Drivers Behind CSCO's 30-Day Stock Rally

The 30-day rally in CSCO stock was primarily propelled by heightened investor enthusiasm for AI infrastructure. Cisco's networking gear is critical for AI data centers, with Q2 results underscoring surging demand in this area. Revenue hit $15.3 billion, up 10% year-over-year, and EPS (earnings per share) reached $1.04, beating estimates.

Previews for Q3 earnings, expected around May 13, fueled optimism, with analysts projecting continued profit growth. Despite some downgrades, such as Zacks Research to Hold in mid-April and BWG Global's shift to Mixed, overall sentiment stayed positive. Broader market trends in technology, including AI hype, amplified the upward momentum, pushing shares to fresh highs. In my view, this momentum feels sustainable given the fundamentals.

What Fueled CSCO's Performance Over the Quarter

Quarterly gains stemmed from a rebound following Q2 earnings released on February 11. While revenue and EPS exceeded forecasts, shares plunged over 12% the next day amid concerns over margins, guidance, and the $28 billion Splunk acquisition's impact on debt. Recovery gathered pace through March and April as AI networking demand solidified, with management emphasizing double-digit growth.

Macroeconomic factors like stabilizing interest rates and enterprise IT spending supported the tech sector. Institutional buying and Cisco's competitive edge in secure networking contributed to sustained upward pressure, outweighing periodic pullbacks from analyst caution on sales growth. I'm watching these macro tailwinds closely as they could extend the trend.

Trending AI Robots

One resource I rely on for insights into AI-driven strategies is Tickeron’s Trending AI Robots page. It showcases the platform's top-performing AI-driven trading bots from a library of hundreds scanning thousands of tickers. These bots employ diverse strategies, including pattern recognition, momentum trading, and mean reversion across various timeframes, with performance metrics like win rate, profit factor, and drawdown clearly displayed. Curated for relevance and recent success, the section helps me identify bots suited to current market trends, such as AI infrastructure plays. I often explore the page to discover bots that align with my trading style and review their live results before incorporating ideas into my analysis.

CSCO Stock Outlook: Key Factors to Watch Next

Investors should monitor Cisco's Q3 FY2026 earnings for updates on AI orders, subscription revenue growth (ARR), and Splunk integration progress. Industry trends in data center expansion and cybersecurity threats remain pivotal. Macro conditions, including Federal Reserve rate decisions and global IT budgets, could sway sentiment. Strategic partnerships or M&A (mergers and acquisitions) developments, alongside competitive pressures from rivals, warrant attention. Key risks include supply chain disruptions and margin compression. This is important because these elements will shape near-term price action.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: CSCO

CSCO in +3.12% Uptrend, advancing for three consecutive days on July 31, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CSCO advanced for three days, in of 362 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 29, 2026. You may want to consider a long position or call options on CSCO as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CSCO just turned positive on July 30, 2026. Looking at past instances where CSCO's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

CSCO moved above its 50-day moving average on August 04, 2026 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The 10-day moving average for CSCO crossed bearishly below the 50-day moving average on July 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CSCO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CSCO broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CSCO entered a downward trend on July 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. CSCO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.823) is normal, around the industry mean (7.283). P/E Ratio (40.580) is within average values for comparable stocks, (75.712). Projected Growth (PEG Ratio) (1.689) is also within normal values, averaging (1.260). Dividend Yield (0.014) settles around the average of (0.016) among similar stocks. P/S Ratio (7.987) is also within normal values, averaging (14.744).

Notable companies

The most notable companies in this group are Cisco Systems (NASDAQ:CSCO), Hewlett Packard Enterprise Company (NYSE:HPE), Lumentum Holdings (NASDAQ:LITE), Ciena Corp (NYSE:CIEN), Nokia Corp (NYSE:NOK), Ericsson (NASDAQ:ERIC).

Industry description

The Telecommunications Equipment industry produces voice and data communications equipment, which includes fiber optic delivery products, digital signal processors, high-speed voice, data and video delivery. Additionally, satellite systems, global positioning systems, wireless data systems, personal communications equipment, telephone handsets and payload equipment for satellites also fall into this category. Apple Inc., QUALCOMM Incorporated and Nokia are major global players in this segment.

Market Cap

The average market capitalization across the Telecommunications Equipment Industry is 22.01B. The market cap for tickers in the group ranges from 1.59K to 479.83B. CSCO holds the highest valuation in this group at 479.83B. The lowest valued company is ABILF at 1.59K.

High and low price notable news

The average weekly price growth across all stocks in the Telecommunications Equipment Industry was 11%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 36%. AAOI experienced the highest price growth at 49%, while CLRO experienced the biggest fall at -21%.

Volume

The average weekly volume growth across all stocks in the Telecommunications Equipment Industry was -2%. For the same stocks of the Industry, the average monthly volume growth was -8% and the average quarterly volume growth was 1%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 56
Price Growth Rating: 49
SMR Rating: 74
Profit Risk Rating: 74
Seasonality Score: -4 (-100 ... +100)
View a ticker or compare two or three
CSCO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of Internet Protocol based networking products and services related to the communications and information technology industry

Industry TelecommunicationsEquipment

Profile
Details
Industry
Computer Communications
Address
170 West Tasman Drive
Phone
+1 408 526-4000
Employees
86200
Web
https://www.cisco.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.